Leeds University study reveals potential biomarker to monitor GIST progression Jan. 24, 2012 No Comments
Chemotherapy combined with radiation shows promise in oligodendroglioma subtype Jan. 24, 2012 No Comments
FDA authorizes marketing of Quest Diagnostics test and label change for Tysabri Jan. 24, 2012 No Comments
RSS